To increase the number of manufacturers registered under the Controlled Substances Act to manufacture cannabis for legitimate research purposes, to authorize health care providers of the Department of Veterans Affairs to provide recommendations to veterans regarding participation in federally-approved cannabis clinical trials, and for other purposes.

United States第115届国会HR-5634House of Representatives
更新于：2018年9月13日

摘要

暂无摘要。

法案文本

可用版本
Introduced (House)查看官方文本

有 1 个可用版本

已显示全部可用记录。

时间线

  1. Introduced in House

  2. Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

  3. Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

    House of Representatives

  4. Ordered to be Reported (Amended) by Voice Vote.

    House of Representatives